Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Carrie Ho, MD

Photo of Carrie Ho, MD
Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue, #0
San Francisco CA 94143
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-4437-9377 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Washington/Fred Hutchinson Cancer Center, Seattle, WA06/2024Hematology/Oncology
    Hospital of the University of Pennsylvania, Philadelphia, PA06/2021Chief Resident, Internal Medicine
    Hospital of the University of Pennsylvania, Philadelphia, PA06/2020Internal Medicine
    The Ohio State University College of Medicine, Columbus, OHMD05/2017Medicine
    Duke University, Durham, NCBA05/2012Computer Science
    Collapse awards and honors
    2024ASH Abstract Achievement Award

    Collapse Overview 
    Collapse overview
    Dr. Carrie Ho is a hematologist-oncologist specializing in blood cancers, including Hodgkin and non-Hodgkin lymphomas and chronic lymphocytic leukemia. She has expertise in advanced therapies such as stem cell transplantation and CAR T-cell therapy. Her research focuses on clinical trials evaluating novel targeted agents and immunotherapies, with a parallel interest in understanding and improving patient-reported outcomes. She is committed to developing more effective, less toxic treatment strategies for patients with lymphoma.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Blood. 2025 Jul 15. Brooks TR, Zabor EC, Bedelu Y, Yang X, Karimi YH, Nedved AN, Wang Y, Dave NK, Landsburg DJ, Baron K, Hu B, Trotier D, Pophali PA, Miller J, Grover NS, Reinert C, Major A, Schwarz T, Patel K, Salafian K, Ayers EC, Sundaram S, Brody JD, McKenna M, Tiger YKR, Sears-Smith M, Ghosh N, Peterson C, Khan C, Bliven SP, Narkhede M, Gibson A, Kline J, Munoz J, Garza Morales R, Ho C, Smith SD, Niu A, Hernandez-Ilizaliturri FJ, Chinyengetere F, Dave SS, Abdel-Razeq N, Alhaj Moustafa M, Caimi P, Hill BT. PMID: 40663785.
      View in: PubMed   Mentions: 1     Fields:    
    2. Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. Am J Hematol. 2025 Sep; 100(9):1709-1713. Miller CR, Huang Y, Allan JN, Bhat SA, Bond D, Brander D, Byrd JC, Chavez J, Chong E, Danilov A, Dowling MR, Dvorak-Kornaus K, Hampel PJ, Ho C, Islam P, Malakhov N, Matasar M, Miller S, Parikh SA, Rabe KG, Rhodes JM, Roeker LE, Rogers KA, Saha A, Skarbnik A, Scott H, Schade J, Shadman M, Shouse G, Sojitra P, Stephens DM, Thompson MC, Thompson PA, Wang Y, Woyach JA, Yano M, Omer Z, Kittai AS. PMID: 40600589.
      View in: PubMed   Mentions:    Fields:    
    3. Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. Haematologica. 2025 Mar 01; 110(3):706-714. Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. PMID: 39540227; PMCID: PMC11873705.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL. Blood Cancer J. 2025 Feb 20; 15(1):23. Kittai AS, Huang Y, Miller S, Allan JN, Bhat SA, Bond DA, Brander DM, Byrd JC, Chavez JC, Chong E, Davids MS, Danilov AV, Ding W, Dowling MR, Dvorak-Kornaus K, Freedman H, Hampel PJ, Ho C, Hwang SR, Islam P, Malakhov N, Matasar M, Miller C, Omer Z, Parikh SA, Parry E, Rabe KG, Raess PW, Rai M, Roeker L, Rhodes J, Rogers KA, Saha A, Schade J, Scott HW, Shadman M, Shouse G, Skarbnik A, Spurgeon S, Stephens DM, Thompson MC, Thompson PA, Wang Y, Yano M, Woyach JA. PMID: 39979241; PMCID: PMC11842760.
      View in: PubMed   Mentions: 4     Fields:    
    5. Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody. Clin Lymphoma Myeloma Leuk. 2025 May; 25(5):337-348.e2. Ramasamy K, Vij R, Kuter D, Cella D, Durie BGM, Abonour R, Rifkin RM, Ailawadhi S, Lee HC, Cowan AJ, Ho C, Dhanasiri S, Fish S, Yu E, Dhamane AD, Fang J, Marshall TS, Samuel A, Liu L, Katz J, Gu T, Jagannath S. PMID: 39799046.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. A phase 2 study of frontline pembrolizumab in follicular lymphoma. EJHaem. 2024 Dec; 5(6):1173-1181. Ho C, Zhu S, Gooley T, Gujral TS, Lynch RC, Poh C, Shadman M, Smith SD, Tseng Y, Gopal AK. PMID: 39691260; PMCID: PMC11647716.
      View in: PubMed   Mentions:
    7. More than a lonca-shot: beating the odds in relapsed/ refractory diffuse large B-cell lymphoma. Haematologica. 2024 04 01; 109(4):1022-1024. Ho C, Smith SD. PMID: 37794796; PMCID: PMC10985445.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. J Clin Oncol. 2024 Jun 10; 42(17):2071-2079. Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. PMID: 38552193.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    9. Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):e33-e39.e1. Ho C, Gopal AK, Till BG, Shadman M, Lynch RC, Cowan AJ, Wu QV, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Cassaday RD, Fromm JR, Fang M, Smith SD. PMID: 37926672; PMCID: PMC10841534.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Adoptive T-cell therapy for Hodgkin lymphoma. Blood Adv. 2021 10 26; 5(20):4291-4302. Ho C, Ruella M, Levine BL, Svoboda J. PMID: 34610100; PMCID: PMC8945637.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    11. Predicting Outcomes following Anti-CD19 CAR T Cell Therapy in Aggressive B Cell Lymphomas. Transplant Cell Ther. 2021 03; 27(3):195-196. Ho C, Svoboda J. PMID: 33781514.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients. Lung. 2018 08; 196(4):435-439. Ho C, Hayes D, Khosravi M, Splaingard ML, Tumin D, Lloyd EA. PMID: 29797070.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Characterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green Monkeys. J Virol. 2016 10 01; 90(19):8795-808. Himes JE, Ho C, Nguyen QN, Amos JD, Xu H, Chan C, Chow SC, Ochsenbauer C, Kaidarova Z, Keating SM, Fouda GG, Permar SR. PMID: 27466415; PMCID: PMC5021398.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    14. Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk. Proc Natl Acad Sci U S A. 2013 Nov 05; 110(45):18220-5. Fouda GG, Jaeger FH, Amos JD, Ho C, Kunz EL, Anasti K, Stamper LW, Liebl BE, Barbas KH, Ohashi T, Moseley MA, Liao HX, Erickson HP, Alam SM, Permar SR. PMID: 24145401; PMCID: PMC3831436.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCellsPHPublic Health
    15. Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys. J Virol. 2013 Oct; 87(20):11121-34. Amos JD, Wilks AB, Fouda GG, Smith SD, Colvin L, Mahlokozera T, Ho C, Beck K, Overman RG, DeMarco CT, Hodge TL, LaBranche CC, Montefiori DC, Denny TN, Liao HX, Tomaras GD, Moody MA, Permar SR. PMID: 23926338; PMCID: PMC3807290.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    16. Transient compartmentalization of simian immunodeficiency virus variants in the breast milk of african green monkeys. J Virol. 2013 Oct; 87(20):11292-9. Ho C, Wu S, Amos JD, Colvin L, Smith SD, Wilks AB, Demarco CT, Brinkley C, Denny TN, Schmitz JE, Rodrigo AG, Permar SR. PMID: 23926337; PMCID: PMC3807282.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    Carrie's Networks
    Concepts (84)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.